Siflon Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 1.04 Cr
- Company Age 19 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.83 Cr
- Satisfied Charges ₹ 19.82 Cr
- Revenue Growth -21.76%
- Profit Growth -88.32%
- Ebitda -61.00%
- Net Worth 2.71%
- Total Assets 2.33%
About Siflon Drugs And Pharmaceuticals
Siflon Drugs And Pharmaceuticals Private Limited (SDAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 January 2006 and has a history of 19 years. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Siflon Drugs And Pharnaceuticals Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.04 Cr.
The company currently has active open charges totaling ₹9.83 Cr. The company has closed loans amounting to ₹19.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ananthaiah Rallapalli, Parvathi Rallapalli, and Swetha Rallapalli serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2006PTC048931
- Company No.
048931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Siflon Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swetha Rallapalli  | Managing Director | 28-Jul-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ananthaiah Rallapalli | Director | 30-Jan-2006 | Current |
| Parvathi Rallapalli | Director | 30-Jan-2006 | Current |
Financial Performance of Siflon Drugs And Pharmaceuticals.
Siflon Drugs And Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 21.76% decrease. The company also saw a substantial fall in profitability, with a 88.32% decrease in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siflon Drugs And Pharmaceuticals?
Unlock access to Siflon Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Siflon Polymers Private LimitedAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Drugs Private LimitedAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Pharma Private LimitedAnanthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
- Siflon Engineering Private Limited
Ananthaiah Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Charges (Loans)
₹9.83 Cr
₹19.82 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.81 Cr
- Axis Bank Limited : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2022 | State Bank Of India | ₹9.81 Cr | Open |
| 24 Feb 2015 | Axis Bank Limited | ₹0.24 M | Open |
| 30 Jul 2020 | Others | ₹4.57 M | Satisfied |
| 30 Jul 2018 | Axis Bank Limited | ₹10.90 Cr | Satisfied |
| 12 Jun 2017 | Others | ₹6.56 Cr | Satisfied |
How Many Employees Work at Siflon Drugs And Pharmaceuticals?
Siflon Drugs And Pharmaceuticals has a workforce of 95 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siflon Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.